NEUXENTRO Trademark

Trademark Overview

On Tuesday, November 17, 2020, a trademark application was filed for NEUXENTRO with the United States Patent and Trademark Office. The USPTO has given the NEUXENTRO trademark a serial number of 90324485. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 29, 2022. This trademark is owned by Karuna Therapeutics, Inc.. The NEUXENTRO trademark is filed in the Pharmaceutical Products category with the following description:

prescription medications for the treatment of neuropsychiatric disorders
neuxentro

General Information

Serial Number90324485
Word MarkNEUXENTRO
Filing DateTuesday, November 17, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 29, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Goods and Servicesprescription medications for the treatment of neuropsychiatric disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKaruna Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NameKaruna Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Monday, August 29, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 29, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2022SOU EXTENSION 1 GRANTED
Monday, January 10, 2022SOU EXTENSION 1 FILED
Monday, January 10, 2022TEAS EXTENSION RECEIVED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 28, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, April 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 28, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, April 28, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 28, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, April 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 28, 2021ASSIGNED TO EXAMINER
Saturday, January 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

neuxentro disorders neuropsychiatric treatment medications prescription